Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 182Leukemia 128Lymphoma 91Leukemia, Myeloid, Acute 83Myelodysplastic Syndromes 64Burkitt Lymphoma 59Lymphoma, Non-Hodgkin 53Lymphoma, Large B-Cell, Diffuse 42Leukemia, Myeloid, Accelerated Phase 39Leukemia, Lymphocytic, Chronic, B-Cell 39Lymphoma, Mantle-Cell 38Hodgkin Disease 38Graft vs Host Disease 36Blast Crisis 35Congenital Abnormalities 34Multiple Myeloma 33Lymphoma, Follicular 33Leukemia, Myeloid, Chronic-Phase 33Myeloproliferative Disorders 32Recurrence 30Breast Neoplasms 29Leukemia, Myelomonocytic, Chronic 28Primary Myelofibrosis 26Lymphoma, Large-Cell, Immunoblastic 26Lymphoma, B-Cell, Marginal Zone 25Neoplasms, Plasma Cell 22Osteosarcoma 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 21Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia, Biphenotypic, Acute 20

Interventions

Cisplatin 3sodium thiosulfate 2Acetylcysteine 2Vorinostat 1Surveys and Questionnaires 1Radiosurgery 1Pantoprazole 1Methotrexate 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Hearing Tests 1Genetic Association Studies 1Dexamethasone 1Audiometry 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ototoxicity × Methotrexate × Clear all
NCT01848457 2020-03-16

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Children's Hospital of Philadelphia

Phase 2 Completed
13 enrolled 15 charts
Sarcoma

Ototoxicity, Neoplasms, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡